HYCAMTIN (GlaxoSmithKline LLC)
Welcome to the PulseAid listing for the HYCAMTIN drug offered from GlaxoSmithKline LLC. This Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | GlaxoSmithKline LLC |
| NON-PROPRIETARY NAME: | topotecan hydrochloride |
| SUBSTANCE NAME: | TOPOTECAN HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2008-09-16 |
| END MARKETING DATE: | 0000-00-00 |
HYCAMTIN HUMAN PRESCRIPTION DRUG Details:
| Item Description | HYCAMTIN from GlaxoSmithKline LLC |
| LABELER NAME: | GlaxoSmithKline LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.25(mg/1) |
| START MARKETING DATE: | 2008-09-16 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0007-4205_7113d074-3995-4ed4-adb8-fbd6ec053148 |
| PRODUCT NDC: | 0007-4205 |
| APPLICATION NUMBER: | NDA020981 |
Other TOPOTECAN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
